Search Results - "García Pajares, F."

Hepatobiliary and Pancreatic: Sertraline‐induced vanishing bile duct syndrome treated with plasmapheresis by Tejedor‐Tejada, J, García‐Pajares, F, Madrigal Rubiales, B

Get full text

Metabolic Syndrome After Liver Transplantation: Five-Year Prevalence and Risk Factors by García-Pajares, F, Peñas-Herrero, I, Sánchez-Ocaña, R, Torrres-Yuste, R, Cimavilla-Román, M, Carbajo-López, A, Almohalla-Alvarez, C, Pérez-Saborido, B, Muñoz-Conejero, E, Gonzalez-Sagrado, M, Caro-Patón, A, Sánchez-Antolín, G

“…Abstract Survival after orthotopic liver transplantation (OLT) has increased over the last decades, focusing on the metabolic complications that contribute to…”
Get full text

Severe Anemia, Gastric Ulcer, Pneumonitis and Cholangitis in a Liver Transplant Patient: Multiple Organic Dysfunction and One Etiology: A Case Report by García-Pajares, F, Santos-Santamarta, F, Fernández-Fontecha, E, Sánchez-Ocaña, R, Amo-Alonso, R, Loza-Vargas, A, Madrigal, B, Pérez-Saborido, B, Almohalla, C, Sánchez-Antolín, G

“…Abstract Cytomegalovirus (CMV) is the most common viral pathogen that negatively affects the outcome of liver transplantation. CMV causes febrile illness often…”
Get full text

Milan Criteria Versus San Francisco Criteria in Hepatocellular Carcinoma: Our Center's Experience by Sánchez Antolín, G, García Pajares, F, Pérez, E, Villacastín, E, Ruiz Rebollo, L, Sánchez, D.P, Cítores, M.A, Velicia Llames, R

“…Abstract Background and aim Liver transplantation (OLT) represents the best treatment for hepatocellular carcinoma (HCC) in advanced cirrhosis showing a 70%…”
Get full text

Incidence, Management, and Results of Vascular Complications After Liver Transplantation by Pérez-Saborido, B, Pacheco-Sánchez, D, Barrera-Rebollo, A, Asensio-Díaz, E, Pinto-Fuentes, P, Sarmentero-Prieto, J.C, Rodríguez-Vielba, P, Martínez-Díaz, R, Gonzalo-Martín, M, Rodríguez, M, Calero-Aguilar, H, Pintado-Garrido, R, García-Pajares, F, Anta-Román, A

“…Abstract Introduction Vascular complications show an 8%–15% incidence after liver transplantation and represent an important cause of mortality. An aggressive…”
Get full text

Covered Metal Stents for the Treatment of Biliary Complications after Orthotopic Liver Transplantation by García-Pajares, F, Sánchez-Antolín, G, Pelayo, S.L, Gómez de la Cuesta, S, Herranz Bachiller, M.T, Pérez-Miranda, M, de La Serna, C, Vallecillo Sande, M.A, Alcaide, N, Llames, R.V, Pacheco, D, Caro-Patón, A

“…Abstract Background Biliary complications, a major source of morbidity after orthotopic liver transplantation (OLT), are increasingly being treated by…”
Get full text

Early and Extended Therapy for Recurrent Hepatitis C after Liver Transplantation by García-Pajares, F, Almohalla, C, Lorenzo Pelayo, S, Ruiz Zorrilla, R, Pinto, P, Ramos, C, Sanchez Antolin, G, Paton, A.C

“…Abstract Background End-stage cirrhosis due to hepatitis C virus (HCV) is one of the most common indications for orthotopic liver transplantation (OLT)…”
Get full text

Cutaneous Mucormycosis Infection by Absidia in Two Consecutive Liver Transplant Patients by García-Pajares, F, Sánchez-Antolín, G, Almohalla Alvárez, C, Madrigal Rubiales, B, Núñez-Rodríguez, H, Sancho del Val, L, Ruiz-Zorrilla, R, Barrera, A, Gómez-Nieto, A, Peñas Herrero, I, Vargas García, A, Caro-Patón, A

“…Abstract Mucormycosis, although an infrequent fungal infection, has a high mortality in patients undergoing orthotopic liver transplantation. We present two…”
Get full text

Risk of Development of the Metabolic Syndrome After Orthotopic Liver Transplantation by Ruiz-Rebollo, M.L, Sánchez-Antolín, G, García-Pajares, F, Fernández-Orcajo, P, González-Sagrado, M, Cítores-Pascual, M.A, Velicia-Llames, R, Caro-Patón, A

“…Longer survival for orthotopic liver transplantation (OLT) patients over the last decade has focused emphasis on the metabolic complications that contribute to…”
Get full text

Hepatocyte growth factor (HGF): a predictor of outcome and response to therapy in hepatitis C? by García-Pajares, F., Caro-Patón Gómez, A.

Get full text

Hepatocyte growth factor (HGF): a predictor of outcome and response to therapy in hepatitis C? by García-Pajares, F, Caro-Patón Gómez, A

Get full text

FibroScan Evaluation of Liver Fibrosis in Liver Transplantation by Sánchez Antolin, G, Garcia Pajares, F, Vallecillo, M.A, Fernandez Orcajo, P, Gómez de la Cuesta, S, Alcaide, No, Gonzalez Sagrado, M, Velicia, R, Caro-Patón, A

“…Abstract Introduction Liver biopsy remains the gold standard to evaluate fibrosis. However, it is invasive and uncomfortable as well as associated with…”
Get full text

Interleukin 18 (IL-18) and other immunological parameters as markers of severity in acute pancreatitis by Martín, M A, Saracíbar, E, Santamaría, A, Arranz, E, Garrote, J A, Almaraz, A, del Olmo, M L, García-Pajares, F, Fernández-Orcajo, P, Velicia, R, Blanco-Quirós, A, Caro-Patón, A

“…Our aim was to prospectively compare the behavior of interleukin 18 (IL-18) levels and other immunological parameters during the first week of hospitalization…”
Get full text

Utility of Oral Anticoagulants as Prophylaxis of Recurrent Portal Thrombosis after Liver Transplantation by Sanchez-Ocaña, R., Tejedor-Tejada, J., Cimavilla-Roman, M., de Benito-Sanz, M., Asensio-Diaz, E., Barrera-Rebollo, A., Perez-Saborido, B., Garcia-Pajares, F., Almohalla-Alvarez, C., Sanchez-Antolin, G.

“…Portal vein thrombosis (PVT) is a relatively common finding in patients undergoing liver transplantation. Although the recommendation to prevent its recurrence…”
Get full text

Efficacy of Direct-acting Antivirals to Improve Clinical Condition, Fibrosis, and Liver Function in Liver Transplant Recipients Infected by Hepatitis C by Garcia-Pajares, F., Tejedor-Tejada, J., Torres-Yuste, R., Almohalla-Alvárez, C., Sánchez-Ocaña, R., Peñas-Herrero, I., Cimavilla-Román, M., de Benito-Sanz, M., Sánchez-Martín, F., Sánchez-Antolín, G.

“…Direct-acting antivirals (DAAs) have revolutionized the treatment of hepatitis C, including transplant recipients with an advanced fibrosis stage. Our aim in…”
Get full text

Impact of dietary intake and nutritional status on outcomes after liver transplantation by de Luis, D A, Izaola, O, Velicia, M C, Sánchez Antolín, G, García Pajares, F, Terroba, M C, Cuellar, L

“…The aim of our study was to examine, in a prospective way, whether any nutritional parameter could predict outcomes after liver transplantation. A nutritional…”
Get full text

807 TRIPLE THERAPY IN CHRONIC HEPATITIS C GENOTYPE 1. LIMITATIONS IN CLINICAL PRACTICE. SPANISH MULTICENTER STUDY by Crespo, J, Sacristan, B, Olcoz, J, Perez, R, Gonzalez, J, Garcia Pajares, F, de la Vega, J, Garcia, R, Saez Royuela, F, Garcia, I, Jimenez, F, Lopez Arias, M, Bailador, C, Cuadrado, A, Milla, A, Urquiza, O, Garcia Riesco, E, Cabezas, J, Menendez, S

Get full text

Indications and Effectiveness of the Mammalian Target of Rapamycin in Liver Transplantation by Sanchez Antolín, G, Garcia Pajares, F, Lorenzo Pelayo, S, Herranz Bachiller, M.T, Almohalla, C, Velicia, R, Caro Paton, A

“…Abstract Background The mammalian target of rapamycin (mTOR) inhibitors are new immunosuppressive drugs for organ transplantation. They are interesting for…”
Get full text

Cirrosis biliar primaria, síndrome "sicca" y anemia hemolítica autoinmune by Cantalapiedra, A., Peñarrubia, M. J., Gutiérrez, O., García-Pajares, F., Núñez, H., García-Frade, J., Caro-Patón, A.

Get full text

Hepatocyte growth factor (HGF): a predictor of outcome and response to therapy in hepatitis C? Factor de crecimiento hepatocitario (HGF): ¿predictor de evolución y de respuesta al tratamiento de la hepatitis C? by F. García-Pajares, A. Caro-Patón Gómez

Get full text